Wenche Nelly A. Rolfsen Sandsborg
Chairman en INDEX PHARMACEUTICALS HOLDING AB .
Fortuna: 738 809 $ al 31/03/2024
Perfil
Wenche Nelly A.
Rolfsen Sandsborg is currently the Chief Executive Officer & Director at Rolfsen Consulting AB.
She is also the Chairman at InDex Pharmaceuticals Holding AB, Chairman at InDex Diagnostics AB, Director at Smartfish AS, Director at Cinclus Pharma Holding AB, and Partner at Serendipity Partners, Inc. Additionally, she is a Partner at Serendipity Partners Management AS since 2016.
In her former positions, Dr. Rolfsen Sandsborg served as the Chief Executive Officer at Quintiles, Inc. (California), Chief Executive Officer & Director at IQVIA Clinical AB, and Chief Executive Officer at InDex Pharmaceuticals AB.
She was also the Vice Chairman at Moberg Pharma AB from 2010 to 2017 and Chairman at Denator AB from 2008 to 2014.
Furthermore, she held various directorial roles at companies such as Aprea Therapeutics AB, BioArctic AB, Bionor Pharma ASA, Aprea Personal AB, Smartfish AB, Swedish Match AB, Axis-Shield Ltd., Artimplant AB, Industrifonden, Recipharm AB, Biovitrum AB, TFS Trial Form Support AB, Navamedic ASA, Aker BioMarine ASA, Jederstrom Pharmaceuticals AB, Apotek Produktion & Laboratorier AB, TFS Trial Form Support International AB, and Swedish Orphan Biovitrum AB.
She also worked as the Managing Director-Pharmacology at Pharmacia AB from 1980 to 1996 and as the Head-Pharmacology at Pharmacia Opthalmics, Inc. from 1980 to 1996.
Additionally, she served as the Vice President-Clinical Trials at IQVIA IES European Holdings from 1996 to 2007 and as the Head-Pharmacology at Pharmacia & Upjohn AB.
Dr. Rolfsen Sandsborg holds a doctorate degree from the University of Uppsala.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
BIOARCTIC AB CLASS B
0.05% | 31/12/2022 | 36 675 ( 0.05% ) | 738 809 $ | 31/03/2024 |
Cargos activos de Wenche Nelly A. Rolfsen Sandsborg
Empresas | Cargo | Inicio |
---|---|---|
INDEX PHARMACEUTICALS HOLDING AB | Chairman | 01/01/2011 |
InDex Diagnostics AB
InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The private company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Chairman | - |
Smartfish AS
Smartfish AS Food RetailRetail Trade Smartfish AS is a holding company that creates drinks for special medical purposes, as well as for people on the go and top athletes to improve their recovery and immune response. It is a research-based company that develops omega 3 based emulsions for brain health, heart health, immune system, and recovery. The firm’s product NutriFriend medical nutrition is sold through pharmacies, medical wholesalers, and directly to hospitals. The company was founded by Janne Sande Mathisen and Henrik Mathisen in 2001 and is headquartered in Oslo, Norway. | Director/Board Member | - |
Serendipity Partners, Inc. | Corporate Officer/Principal | - |
Serendipity Partners
Serendipity Partners Investment ManagersFinance Serendipity Partners Management AS (Serendipity Partners) is a private equity/venture capital firm founded in 2015 by Michael Bodd. The firm is headquartered in Oslo, Norway. | Private Equity Investor | 01/08/2016 |
Rolfsen Consulting AB | Chief Executive Officer | - |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Director/Board Member | - |
Antiguos cargos conocidos de Wenche Nelly A. Rolfsen Sandsborg.
Empresas | Cargo | Fin |
---|---|---|
BIOARCTIC AB | Chairman | 01/06/2023 |
SWEDISH MATCH | Director/Board Member | 27/04/2022 |
░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formación de Wenche Nelly A. Rolfsen Sandsborg.
University of Uppsala | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 5 |
---|---|
INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
NAVAMEDIC ASA | Distribution Services |
MOBERG PHARMA AB | Health Technology |
BIOARCTIC AB | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Empresas privadas | 30 |
---|---|
Swedish Match AB
Swedish Match AB TobaccoConsumer Non-Durables Swedish Match AB engages in the manufacture and trade of lighters and tobacco products. It operates through the following segments: Snus and Moist Snuff; Other Tobacco Products; Lights; and Other Operations. The Snus and Moist Snuff segment produces and markets smokeless cigarettes. The Other Tobacco Products segment manufactures and sells chewing tobacco and cigars. The Lights segment develops and trades matches, lighters, razors, batteries, light bulbs, and toothpicks. The Other Operations segment consists of corporate and Swedish distribution functions.The company was founded in 1992 and is headquartered in Stockholm, Sweden. | Consumer Non-Durables |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Axis-Shield Ltd.
Axis-Shield Ltd. Medical SpecialtiesHealth Technology Axis-Shield Ltd. operates as a biotechnology company. The company was founded 1993 and is headquartered in the United Kingdom. | Health Technology |
Artimplant AB
Artimplant AB Medical SpecialtiesHealth Technology Artimplant AB engages in research and development of biomaterials for solutions to problems in orthopedic, odontological and reconstructive surgery. It also involves in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The company was founded by Anders Cedronius in 1990 and is headquartered in Vastra Frolunda, Sweden. | Health Technology |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Finance |
Recipharm AB
Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
Pharmacia AB | Health Technology |
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Commercial Services |
Aker BioMarine ASA
Aker BioMarine ASA Agricultural Commodities/MillingProcess Industries Aker BioMarine ASA engages in the marine biotechnology industry. It develops and supplies biomarine ingredients to the animal, human nutrition, and pharmaceutical markets. Its core business is harvesting, production, sales and marketing of krill based products. The company was founded in 2006 and is headquartered in Oslo, Norway. | Process Industries |
Pharmacia Opthalmics, Inc. | |
Denator AB
Denator AB Medical SpecialtiesHealth Technology Denator AB provides instruments and consumables that stabilize biological samples. It develops, markets and sells instruments and consumables to address needs in the life science and clinical research markets. The firm's products enable scientists to stabilize biological samples, such as tissue sections or cellular biopsies, from the moment of sampling. The company was founded by Olof Sköld and Karl Sköld in 2004 and is headquartered in Göteborg, Sweden. | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Health Technology |
Jederstrom Pharmaceuticals AB
Jederstrom Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Jederstrom Pharmaceuticals is a life sciences company that is developing new formulations for oral delivery of therapeutic proteins. These new formulations offer new and improved therapeutic possibilities, cost advantages and the convenience factor of oral administration. The vision of Jederstrom Pharmaceuticals is to make oral administration the method of choice for a number of key therapeutic proteins. Jederstrom Pharmaceuticals initial focus is to develop an insulin formulation for oral administration. Formulations of other well-known therapeutic proteins will then be developed. Jederstrom Pharmaceuticals' business model shall be out licensing. Jederstrom Pharmaceuticals was founded in 2001 by Gustaf Jederström, inventor of the formulation technology. Gustaf Jederström has more than 30 years experience of R&D in the pharmaceutical industry, where he has been instrumental in bringing numerous new pharmaceutical products to market. | Health Technology |
Apotek Produktion & Laboratorier AB
Apotek Produktion & Laboratorier AB Pharmaceuticals: MajorHealth Technology Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden. | Health Technology |
IQVIA Clinical AB
IQVIA Clinical AB Pharmaceuticals: MajorHealth Technology IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden. | Health Technology |
TFS Trial Form Support International AB
TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Commercial Services |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway. | Health Technology |
Smartfish AS
Smartfish AS Food RetailRetail Trade Smartfish AS is a holding company that creates drinks for special medical purposes, as well as for people on the go and top athletes to improve their recovery and immune response. It is a research-based company that develops omega 3 based emulsions for brain health, heart health, immune system, and recovery. The firm’s product NutriFriend medical nutrition is sold through pharmacies, medical wholesalers, and directly to hospitals. The company was founded by Janne Sande Mathisen and Henrik Mathisen in 2001 and is headquartered in Oslo, Norway. | Retail Trade |
Aprea Personal AB | |
InDex Diagnostics AB
InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The private company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Health Technology |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Health Technology |
Smartfish AB
Smartfish AB Beverages: Non-AlcoholicConsumer Non-Durables Part of Smartfish AS, Smartfish AB is a Swedish company that focuses on medical nutrition for cancer patients. The private company is based in Solna, Sweden. The company believes that good nutritional status is crucial for successful treatment and optimal outcomes. Smartfish has a slim and flexible organizational structure and aims to grow through strategic relationships with leading R&D, production, and distribution partners. The company's medical nutrition products are used to improve the nutritional status of malnourished or undernourished patients. | Consumer Non-Durables |
Rolfsen Consulting AB | |
Cinclus Pharma AG
Cinclus Pharma AG BiotechnologyHealth Technology Cinclus Pharma AG is a Swiss Swedish pharmaceutical company founded in 2011. Cinclus Pharma is based in Basel, Switzerland. The private company is focused on bringing relief to people suffering from gastric acid related diseases, particularly gastroesophageal reflux disease (GERD). Cinclus Pharma's clinical stage drug candidate, linaprazan glurate, is a new approach to managing GERD and is showing promising results in acid control and lowering the cmax-value. The company was founded by experts in the field of GERD treatment with extensive experience from Astra and Astra Zeneca. | Health Technology |
Serendipity Partners, Inc. | Miscellaneous |
Serendipity Partners
Serendipity Partners Investment ManagersFinance Serendipity Partners Management AS (Serendipity Partners) is a private equity/venture capital firm founded in 2015 by Michael Bodd. The firm is headquartered in Oslo, Norway. | Finance |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Health Technology |
IQVIA IES European Holdings
IQVIA IES European Holdings Advertising/Marketing ServicesCommercial Services IQVIA IES European Holdings provide investment services. The company was founded on November 21, 1996 and is headquartered in Reading, the United Kingdom. | Commercial Services |
Pharmacia & Upjohn AB
Pharmacia & Upjohn AB Pharmaceuticals: MajorHealth Technology Pharmacia & Upjohn AB is a Swedish pharmaceutical company that manufactures drugs. The private company is based in Stockholm, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Wenche Nelly A. Rolfsen Sandsborg